301-315 of 379
IgAN Explained: Key Differences from Other Kidney Conditions
Clinician's RoundtableIgAN Explained: Key Differences from Other Kidney Conditions
Mohamed Ibrahim, MB, BCh
Nutritional Strategies for Managing IgA Nephropathy
Clinician's RoundtableNutritional Strategies for Managing IgA Nephropathy
Jennifer Moore, MS, RDN, CSR, LDN
Charles Turck, PharmD, BCPS, BCCCP
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiersZilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's RoundtableRare Kidney Disease: A Parent and Caregiver’s Perspective
Gates B. Colbert, MD
Kelly Helm
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's RoundtableDecoding Proteinuria: A Window into Kidney Health in IgAN
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiersReducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
Kelly G. Gwathmey, MD
- advertisement
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiersATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
Morie Gertz, MD, MACP
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Gates B. Colbert, MD
Edward Filippone, MD
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Project Oncology®Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Gareth Morgan, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Betsy O'Donnell, MD
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
- advertisement
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiersComprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
John Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiersContinuum of Care: Managing DMD in Pediatric and Adult Patients
John Brandsema, MD
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Morie Gertz, MD, MACP
